Relay Therapeutics, which aims to take down difficult cancer drug targets by combining computational methods with emerging lab tools, has raised a whopping $400 million in its third formal financing ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the formation of Relay Therapeutics with $57 million in Series A financing, including participation from an affiliate of D.